[Improvement of outcomes by primary treatment for temporomandibular disorders].

Shigeru Aoyama, Koji Kino, Hiroshi Iwaki, Teruo Amagasa
{"title":"[Improvement of outcomes by primary treatment for temporomandibular disorders].","authors":"Shigeru Aoyama,&nbsp;Koji Kino,&nbsp;Hiroshi Iwaki,&nbsp;Teruo Amagasa","doi":"10.5357/koubyou.75.150","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study was to survey the current state of the temporomandibular joint disorder treatment in our clinic and to confirm the therapeutic outcomes. The subjects in this study were recruited from among the patients with temporomandibular disorders who attended the Temporomandibular Disorder Special Clinic, Department of Oral Surgery, Hitachi Yokohama Hospital during one year period from February 2007 to January 2008. A total of 100 consecutive outpatients diagnosed with temporomandibular disorders were selected for the study. Pain intensity and the degree to which daily function was limited before and after treatment were evaluated using the Visual Analogue Scale (VAS). The Beck Depression Inventory-II (BDI-II) score was evaluated simultaneously, and the correlation with changes in symptom was evaluated. The median (25th, 75th percentiles) of pain intensity (VAS value) before treated was 45 (25.0, 65.0) and the degree of limitation of daily function (VAS value) was 15 (0.0, 50.0). The median (25th, 75th percentiles) of pain intensity at 4 weeks after was 10 (0.0, 30.0), and significantly lower than that before treatment (p = 0.000). The degree of limitation of daily function was 0 (0.0, 10.0), also significantly lower than that before treatment (p = 0.000). The BDI-II score decreased from 8 (2.0, 11.8) before treatment to 5 (2.0, 11.0, p = 0.024) and showed no significant correlation with the improvement in outcomes by primary treatment for temporomandibular disorders.</p>","PeriodicalId":76076,"journal":{"name":"Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan","volume":"75 3","pages":"150-4"},"PeriodicalIF":0.0000,"publicationDate":"2008-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5357/koubyou.75.150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of this study was to survey the current state of the temporomandibular joint disorder treatment in our clinic and to confirm the therapeutic outcomes. The subjects in this study were recruited from among the patients with temporomandibular disorders who attended the Temporomandibular Disorder Special Clinic, Department of Oral Surgery, Hitachi Yokohama Hospital during one year period from February 2007 to January 2008. A total of 100 consecutive outpatients diagnosed with temporomandibular disorders were selected for the study. Pain intensity and the degree to which daily function was limited before and after treatment were evaluated using the Visual Analogue Scale (VAS). The Beck Depression Inventory-II (BDI-II) score was evaluated simultaneously, and the correlation with changes in symptom was evaluated. The median (25th, 75th percentiles) of pain intensity (VAS value) before treated was 45 (25.0, 65.0) and the degree of limitation of daily function (VAS value) was 15 (0.0, 50.0). The median (25th, 75th percentiles) of pain intensity at 4 weeks after was 10 (0.0, 30.0), and significantly lower than that before treatment (p = 0.000). The degree of limitation of daily function was 0 (0.0, 10.0), also significantly lower than that before treatment (p = 0.000). The BDI-II score decreased from 8 (2.0, 11.8) before treatment to 5 (2.0, 11.0, p = 0.024) and showed no significant correlation with the improvement in outcomes by primary treatment for temporomandibular disorders.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[颞下颌疾病初级治疗改善预后]。
本研究旨在了解我院临床颞下颌关节紊乱的治疗现状,并对治疗效果进行确认。本研究的研究对象从日立横滨医院口腔外科颞下颌疾病专科门诊2007年2月至2008年1月就诊的颞下颌疾病患者中招募。共选择100名连续诊断为颞下颌紊乱的门诊患者进行研究。采用视觉模拟评分法(Visual Analogue Scale, VAS)评价治疗前后疼痛强度和日常功能受限程度。同时进行贝克抑郁量表- ii (BDI-II)评分,并评估与症状变化的相关性。治疗前疼痛强度(VAS值)中位数(25、75百分位数)为45(25.0、65.0),日常功能受限程度(VAS值)为15(0.0、50.0)。治疗后4周疼痛强度中位数(25、75百分位数)为10(0.0、30.0),显著低于治疗前(p = 0.000)。日常功能的限制程度为0(0.0,10.0),也显著低于治疗前(p = 0.000)。BDI-II评分由治疗前的8分(2.0,11.8)降至5分(2.0,11.0,p = 0.024),与原发性颞下颌疾病治疗后预后改善无显著相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Inflammasome Activation and the Associating Diseases. Towards the Understanding of Tumor Microenvironment. Clinical Study of 597 Oral Squamous Cell Carcinomas in Our Department - Especially about 318 Tongue Carcinoma. Oral Function and Dysphagia Rehabilitation. The Scientific Works and Legacy of Prof. Dr. Dr. G. Steinhardt (1904-1995).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1